Cargando…
Comparison of Trehalose/Hyaluronic Acid (HA) vs. 0.001% Hydrocortisone/HA Eyedrops on Signs and Inflammatory Markers in a Desiccating Model of Dry Eye Disease (DED)
Background: Dry eye disease (DED) is a multifactorial disease where ocular surface inflammation and damage play key etiological roles. Purpose: To compare a combination of 3% trehalose (T) and 0.15% hyaluronic acid (HA) (Thealoz duo(®), T/HA) with a tear substitute containing 0.001% hydrocortisone (...
Autores principales: | Astolfi, Gloria, Lorenzini, Luca, Gobbo, Francesca, Sarli, Giuseppe, Versura, Piera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948919/ https://www.ncbi.nlm.nih.gov/pubmed/35329844 http://dx.doi.org/10.3390/jcm11061518 |
Ejemplares similares
-
Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients
por: Fariselli, Chiara, et al.
Publicado: (2018) -
Efficacy of two-month treatment with Xiloial(®) eyedrops for discomfort from disposable soft contact lenses
por: Versura, Piera, et al.
Publicado: (2010) -
Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
por: Jia, XiaoXiao, et al.
Publicado: (2023) -
Use of Hyaluronic Acid (HA) in Chronic Airway Diseases
por: Máiz Carro, Luis, et al.
Publicado: (2020) -
A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome
por: Pinto-Bonilla, Juan Carlos, et al.
Publicado: (2015)